Abstract: DNA nanostructures have become an important and powerful tool for studying protein function over the last 5 years. One of the challenges, though, has been the development of universal methods for patterning protein complexes on DNA nanostructures. Herein, we present a new approach for labeling DNA nanostructures by functionalizing them with a GFP nanobody. We demonstrate the ability to precisely control protein attachment via our nanobody linker using two enzymatic model systems, namely adenylyl cyclase activity and myosin motility. Finally, we test the power of this attachment method by patterning unpurified, endogenously expressed Arp2/3 protein complex from cell lysate. By bridging DNA nanostructures with a fluorescent protein ubiquitous throughout cell and developmental biology and protein biochemistry, this approach significantly streamlines the application of DNA nanostructures as a programmable scaffold in biological studies.
Introduction
DNA nanotechnology provides the ability to precisely control both protein stoichiometry and geometry akin to cellular organization. Over the last few years, researchers have started to apply these strengths to questions of protein ensemble behavior [1] [2] [3] [4] and enzyme pathway dynamics. 5, 6 Further validating their use for biological applications, DNA Additional Supporting Information may be found in the online version of this article.
Broader statement: One of the challenges of DNA nanotechnology has been the development of universal methods for patterning proteins onto nanostructures. Herein, we present a new approach for labeling DNA nanostructures with unpurified, endogenouslyexpressed protein complex using a GFP-nanobody. By bridging DNA nanostructures with a fluorescent protein ubiquitous throughout cell and developmental biology and protein biochemistry, this approach significantly streamlines the application of DNA nanostructures as a programmable scaffold in biological studies.
nanostructures remain highly stable and functional in cell lysate. 7 One of the major barriers, however, has been the attachment of proteins of interest to DNA nanostructures. One method is directly crosslinking short DNA attachment oligos to the target protein. 5, 6 Many proteins, though, have limited stability, and thus even mild chemical modification may lead to enzyme inactivation. Alternative methods include using a secondary attachment protein tag such as DNA aptamer binding proteins, 8 biotinstreptavidin based linkages, 9,10 unnatural amino acids, 11 or small labeling proteins such as "SNAP" or "Halo" tags. [1] [2] [3] [4] 10, 12 In particular, SNAP and Halo tags have been used because they allow direct labeling of the protein of interest to specific DNA oligos and thus provide the needed specificity for multiprotein scaffolds. Limitations of these methods, though, are that proteins have to be re-engineered with the protein tags, additional purification methods are still required to remove excess label, and there is often a trade-off between labeling efficiency and protein stability. To be more widely applicable, an attachment system is needed which takes advantage of the widespread use of specific protein tags throughout the biological sciences, such as the fluorescent family of GFP proteins.
Here we present a technical advance for labeling of DNA nanostructures using a nanobody attachment strategy. Nanobodies are small (12-15 kDa), monomeric, single-domain antibodies that bind to their antigens strongly with dissociation constants in the picomolar to nanomolar range. 13 Nanobodies have been produced using a variety of expression systems to high purity and are extremely stable. 13 We used a GFP-nanobody that can recognize both GFP and YFP and has one-to-one stoichiometric binding to GFP with a K D < 2 nM. 14, 15 We test the stoichiometric control of our nanobody-based attachment system using two previously published protein assay systems: adenylyl cyclase enzymatic activity 16 and actin-based myosin VI motility. 2 Finally, we demonstrate the strength of this approach by patterning endogenously expressed yeast Arp2/3 complex on DNA nanostructures.
Results
We designed our GFP-nanobody with a SNAP tag for single-stranded, Cy3-oligo DNA labeling. We tested this nanobody using a Cy5-labeled flat rectangular DNA nanostructure (100 nm 3 80 nm) with a biotin purification tag and 1-6 protein attachment sites 4 (Supporting Information Fig. S1 ). These attachment sites allow us to specifically decorate our nanostructures with Cy3-oligo labeled GFPnanobodies, as illustrated in the 0.67% agarose 0.1% SDS gel [ Fig. 1(A,B) ]. We performed two distinct tests to evaluate stoichiometric binding through the GFP nanobody. We first tested our system via an enzymatic chemical reaction using adenylyl cyclase 16 ( Fig. 1) . Adenylyl cyclase is a key signaling enzyme in the cell which converts adenosine triphosphate (ATP) into 3 0 ,5 0 -cyclic AMP (cAMP). 17 Using 0.67% agarose 0.1% SDS gels and Cy5 intensity to correct for total amount of nanostructures, we measured the forskolin-stimulated enzymatic activity of adenylyl cyclase on nanostructures bound to magnetic beads with one, two or four attachment sites. Labeled nanostructures show a clear linear increase in enzymatic activity relative to the number of attachment sites [R 2 5 0.87; Fig. 1 
The second system we used to test our nanobody-based adaptor was the collective movement of myosin VI motor proteins on a model 2D cellular actin network [ Fig. 2(A,B) ]. Myosin VI is an ATP-driven molecular motor that is involved in numerous intracellular processes such as the movement and transportation of cargo and organelles throughout the cell. 18 Previous work from our group has shown that the run length for myosin-bound nanostructures on model cellular actin networks isolated from fish keratocytes increases with increasing motor number. 2 In addition to higher complexity, this assay also tests the stability of nanobody-protein . Finally, we demonstrate the power of this approach by patterning endogenously expressed protein complex from cellular lysate onto our DNA nanostructures. We took advantage of the Saccharomyces cerevisiae yeast GFP clone collection generated by Huh et al. 19 Huh et al. used homologous recombination to create a collection of strains expressing full-length, chromosomally-tagged GFP fusion proteins. We selected two strains expressing GFP-tagged subunits of the Arp2/3 complex, ArpC3 and ArpC4 (Fig. 3) . The Arp2/3 complex is a stable seven-component protein complex that plays a crucial role in regulating the cellular actin network. 20 As illustrated in Figure 3 (A), we used nanobodylabeled DNA nanostructures to pull out the GFPtagged subunit from yeast lysate and then assessed the presence of Arp2 by Western blotting. For both GFP-tagged ArpC3 and ArpC4, the amount of Arp2 scales with the number of nanobody proteins on the nanostructures [ Fig. 3(B,C) ].
Discussion
Overall, this study establishes the broad utility of nanobody-based attachment to control protein labeling of DNA nanostructures. As fluorescently tagged proteins are widely available in both cell lines and animal models, this system demonstrates a simple approach for precisely patterning endogenous protein complexes straight from cellular lysates on to DNA nanostructures. As with co-immunoprecipitation experiments, these pull-downs do not require large amounts of starting material (10 mg/mL). Unlike coimmunoprecipitation, however, this technique enables one to label DNA nanostructures with precisely controlled geometry and stoichiometry. Besides demonstrating the feasibility of this technical advance for GFP-tagged proteins, it can easily be expanded to other nanobody-or monobody-based attachment systems. 13, 21 Overall, this approach will expand the utility of DNA nanostructures to biological questions, such as the impact of microdomains on protein behavior and function.
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Materials and Methods
Nanobody-SNAP preparation
The DNA sequence for the GFP-nanobody was generated and synthesized by Genewiz off of the previously published "enhancer" GFP-nanobody sequence.
14,15 The SNAP-tagged nanobody construct contained from N-to C-terminus: the GFPnanobody, a flexible (Gly-Ser-Gly) 2 linker, the SNAPtag for oligo labeling, and both FLAG and 6xHis purification tags. Protein was expressed in Sf9 cells by transient transfection (pBiex-1; Escort IV, Sigma), and affinity purified at 72 h using anti-FLAG M2 affinity resin (Sigma) similar to previously published protocols. 16 Nanobody bound to anti-FLAG resin was incubated with excess (>10 lM) BG-oligo-Cy3 in wash buffer (20 mM imidazole, 150 mM KCl, 5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 lg/ mL PMSF, 10 lg/mL aprotinin, 10 lg/mL leupeptin, pH 7.4) at 378C for 30 min followed by overnight incubation at 48C, with continuous mixing during both steps. 4 Labeled-nanobody bound to resin was washed with wash buffer and eluted using 0.2 mg/ mL FLAG peptide (Sigma). Protein labeling was confirmed by a 10% SDS gel followed by Coomassie staining and Cy3-imaging with a Typhoon gel imager (GE Healthcare). The protein was stored in 55% glycerol (v/v) at 2208C.
Benzyl-guanine-labeled oligonucleotide preparation
Briefly, 0.17 mM C6-amine-oligo5-Cy3 (Supporting Information Table S1 ) was incubated with 11.6 mM benzyl-guanine NHS ester (NEB) for 4 h at 378C with shaking at 1000 rpm. Labeled oligo was then purified twice into 2 mM Tris, pH 8.5 using Illustra ProbQuant G-50 micro columns (GE Healthcare). 4 Oligo concentration was determined from Cy3 intensity using a NanoDrop spectrophotometer.
Adenylyl cyclase and myosin VI preparation
Adenylyl cyclase constructs were based off of a previously published study. 16 Briefly, the cytoplasmic domains from isoform II and V (C2, isoform II; C1a, isoform V) were joined by a 30 nm linker, and fused with eGFP and a FLAG purification tag at the Cterminus. Adenylyl cyclase was expressed in Sf9 cells, purified as previously described, and used within 2 days of purification for maximal activity. 16 Myosin VI constructs contain from N-to C-terminus: residues 1-992 of Sus scrofa myosin VI (containing both the IQ and SAH domains), a leucine zipper for dimerization [GCN4], 24 eGFP, and a FLAG purification tag. Myosin VI was purified similar to previously described methods and stored in 55% glycerol (v/ v) at 2208C.
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Scaffold labeling and preparation
Cy5-labeled DNA nanostructures were prepared based on the detailed description in previous work from our lab. 3, 4 Briefly, a list of strand sequences is provided in Supporting Information Table S1 . Each scaffold contains 23 Cy5 molecules for imaging and a biotinylated strand to facilitate purification of nanostructures. For formation of nanostructures, single-stranded M13mp18 DNA (NEB) was mixed with excess of short staple strands (IDT) in TAEMg 21 buffer (40 mM Tris, 20 mM acetic acid, 1 mM EDTA, 12.5 mM MgCl 2 ) followed by the annealing protocol listed in Supporting Information Table S2 . For nanobody-labeling, Cy5-nanostructures were incubated for 10-15 min with streptavidin-coated magnetic beads (NEB) at 308C with shaking in the appropriate reaction buffer containing 1 mg/mL BSA and 5-10 nM of a mixture of 42-nucleotide oligos with randomized sequences (blocking oligos). Resin was washed three times and then incubated with excess Cy3-labeled nanobody for 10-15 min at 308C with shaking.
Adenylyl cyclase activity
Five-to ten-fold excess adenylyl cyclase was incubated with nanobody-labeled nanostructures bound to magnetic resin for 10 min at 308C with shaking in AC buffer [50 mM HEPES pH 8.0, 5 mM MgCl 2 , 50 mM NaCl, 1 mM DTT, 1 mg/mL BSA, and 5-10 nM 42-nucleotide mix]. Resin was washed three times with AC buffer, and then incubated at 308C with shaking for 30 min in 50 mL AC buffer containing 100 mM ATP and 100 mM forskolin (Sigma). At the end of 30 min, the reaction solution was removed from resin, separated into two 25 mL aliquots, and mixed with Kinase-Glo Max luminescent assay mix (Promega). End-point luminescence was measured in white, 96-well plates using an M5e Spectramax spectrophotometer (Molecular Devices) and corrected for pyrophosphate inhibition. Magnetic resin was washed with AC buffer, eluted with excess elution strand for 10-15 min at 308C, and run on a 0.67% agarose 0.1% SDS gel to correct for nanostructure concentration.
Myosin motility assay
GFP-tagged myosin VI was incubated with nanobodylabeled nanostructures bound to magnetic resin and eluted in AB buffer (AB; 25 mM imidazole pH 7.4, 25 mM KCl, 4 mM MgCl 2 , 1 mM EGTA, 1 mM DTT, 1 mg/mL BSA, and 5-10 nM random 42-nucleotide DNA mix) with 1-2 mM elution strand according to Ref. 4 . Keratocytes were derived from scales of Rocio octofasciata (Jack Dempsey Cichlids) as previously described. 25 All protocols conform to the guidelines of the local animal care and use committee (IACUC). Extraction of actin networks, elution of myosin VIlabeled nanostructures, imaging of myosin-driven nanostructure movement, and trajectory analysis followed previously published methods.
3,4
Yeast Arp2/3 complex binding S. cerevisiae expressing GFP-tagged ArpC3 (YLR370C) and ArpC4 (YKL013C) in an ATCC 201388 background (strain BY4741; MATa his3D1 leu2D0 met15D0 ura3D0) were selected from the Yeast GFP Clone Collection (Invitrogen). 19 Yeast were grown in SD/-His minimal media (Clontech) at 308C, and lysed by repetitive liquid N 2 freezing and grinding in YB buffer (50 mM HEPES pH 7.5, 100 mM KCl, 1 mM EGTA, 3 mM MgCl 2 , 1 mM DTT, 50 lg/mL PMSF, 5 lg/mL aprotinin, and 5 lg/ mL leupeptin). Clarified lysate was incubated with nanobody-labeled nanostructures bound to magnetic resin for 1 h at 48C. Resin was washed three times with YB.BN buffer (YB buffer 1 1 mg/mL BSA, and 5-10 nM random nucleotide mix), and then incubated at 308C with shaking for 10 min in 40 mL YB.BN buffer containing 1-2 mM elution strand. Elute was run on a 10% SDS gel and scanned for nanobody fluorescence on a Typhoon gel imager (GE Healthcare) before being transferred similar to previous published protocols. 26 Primary goat anti-Arp2 antibody (SC-11969, Santa Cruz Biotechnology) was used at a concentration of 1:200 and mouse antigoat secondary antibody (Jackson ImmunoResearch Laboratories) at 1:20,000. Blots were developed using Immobilon Western chemiluminescent HRP substrate (Millipore) and an Odyssey FC imaging system (LI-COR).
